Houlihan Lokey Advises Ridgemont Equity Partners

Houlihan Lokey is pleased to announce that Ridgemont Equity Partners (Ridgemont) has acquired American Outcomes Management (AOM). The transaction closed on February 18, 2022.

Ridgemont is a Charlotte-based middle-market buyout and growth equity investor. Since 1993, the principals of Ridgemont have invested over $5.5 billion. The firm focuses on equity investments of up to $250 million and utilizes a proven, industry-focused investment approach and repeatable value creation strategies.

Founded in 1994 with pharmacy licenses in all 50 states, AOM is a leading specialty infusion provider focused on home-based intravenous immunoglobulin (IVIG) therapy. AOM services patients with over 80 different chronic conditions, with long-term treatment administered by skilled infusion nurses. The company also provides support services, including pharmacy services, referral management, insurance verification, and patient education and training.

This transaction further strengthens and highlights Houlihan Lokey’s continued leadership in the pharmacy space, and more specifically the home infusion sector. Houlihan Lokey’s Healthcare Group is among the largest dedicated healthcare investment banking groups in the world. In 2021, the group closed 43 transactions and was ranked the No. 1 M&A advisor for global healthcare transactions under $1 billion by Refinitiv.* Houlihan Lokey’s Healthcare Group has closed more than 350 M&A healthcare transactions since its inception.

Houlihan Lokey served as the financial advisor to Ridgemont.